These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A protective network for catching misleading laboratory results is required]. Theodorsson E Lakartidningen; 2002 May; 99(22):2489. PubMed ID: 12092047 [No Abstract] [Full Text] [Related]
4. [Great number of non-recorded cases of analytical interference. Unexpected and misinterpreted laboratory levels can result in diagnostic and therapeutic errors]. Lindstedt G; Ekman R; Forberg R; Isaksson A; Stridsberg M; Hård L; Nordin G; Nyström E Lakartidningen; 2002 May; 99(22):2492-4. PubMed ID: 12092048 [No Abstract] [Full Text] [Related]
5. Introduction to the Good Laboratory Practice Regulations. Cwiertniewicz J Lab Anim (NY); 2005 Mar; 34(3):29-32. PubMed ID: 15735636 [TBL] [Abstract][Full Text] [Related]
6. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
7. A backward step in drug control. Feldman EG J Pharm Sci; 1966 Sep; 55(9):i. PubMed ID: 5918545 [No Abstract] [Full Text] [Related]
8. Coping with CLIA, Part 7. Walking the straight and narrow on quality control. Passey RB MLO Med Lab Obs; 1993 Feb; 25(2):39-43. PubMed ID: 10171371 [No Abstract] [Full Text] [Related]
9. Does the FDA have authority to regulate human cloning? Price EC Harv J Law Technol; 1998; 11(3):619-41. PubMed ID: 12731551 [No Abstract] [Full Text] [Related]
10. Errors in measuring drug concentrations. McCormick W; Ingelfinger JA; Isakson G; Goldman P N Engl J Med; 1978 Nov; 299(20):1118-21. PubMed ID: 703790 [No Abstract] [Full Text] [Related]
11. The evolution of new drug legislation. Kelsey FO BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212 [No Abstract] [Full Text] [Related]
12. Industry view on the regulation of ancillary reagents. Schifreen RS; Louth C Food Drug Law J; 1996; 51(1):155-9. PubMed ID: 11794348 [No Abstract] [Full Text] [Related]
13. Forum on criteria for certification, licensure and quality control of cytology laboratories. Acta Cytol; 1971; 15(6):562-76. PubMed ID: 4944870 [No Abstract] [Full Text] [Related]
14. The Drug Abuse Control Amendments of 1965. R I Med J; 1966 Mar; 49(3):189 passim. PubMed ID: 5217555 [No Abstract] [Full Text] [Related]
15. [The evaluation on the use of double control sera for within-laboratory quality control (author's transl)]. Kamei A; Hashimoto T; Hasegawa T; Sasajima M; Okumura J; Matsubara F Rinsho Byori; 1981 Jan; 29(1):101-5. PubMed ID: 7289095 [No Abstract] [Full Text] [Related]
16. [An approved control system for the clinical chemical laboratory]. Esser F Med Lab (Stuttg); 1973 May; 26(5):111-4. PubMed ID: 4709318 [No Abstract] [Full Text] [Related]
17. One decade of food and drug law scholarship: a selected bibliography. Noah L Food Drug Law J; 2000; 55(4):641-58. PubMed ID: 12025854 [No Abstract] [Full Text] [Related]
18. [Study of the quality of laboratory chemicals and reagents and diagnostic solutions]. Voldán B; Sarsúnová M; Szücsová S Cesk Farm; 1969; 18(7):324-8. PubMed ID: 5349334 [No Abstract] [Full Text] [Related]
19. A timely re-examination of drug polymorphism in pharmaceutical development and regulation. Grant DJ; Byrn SR Adv Drug Deliv Rev; 2004 Feb; 56(3):237-9. PubMed ID: 14962580 [No Abstract] [Full Text] [Related]